If the Medline win helped assuage the former concern, a step-up in the share of its order backlog it can convert into revenue could help ease the latter. Symbotic expects to deliver about 12% of its ...

Interventions reducing or eliminating diabetes medication costs showed variable impacts on adherence, with short-term improvements often diminishing over time. Combining cost-reduction strategies with ...

The most exciting upcoming IPOs include design platform Canva and digital asset manager Grayscale Investments.

Objectives To evaluate the available virtual reality (VR) applications for treating perinatal mental health disorders, focusing on their effectiveness in reducing symptoms such as anxiety and ...

Introduction Alcohol is consumed by an estimated 137.4 million people in the USA 12 years of age and older and, as a result, is estimated to have caused about 140 thousand deaths among people 20 to 64 ...

Background Journal editors are responsible for what they publish and therefore have a duty to correct the record if published work is found to be unreliable. One method for such correction is ...

Of course, there are other ethical issues, such as the child's right to choose. An embryo has no say in how the parents alter their genome, as stated by the NYU Grossman School of Medicine. The right ...

Medline is planning an IPO, which might occur between late 2025 and early 2026, aiming for a $5 billion raise. Investors can't buy Medline stock now; consider similar public firms like Cardinal Health ...

CITY HALL SHOWDOWN: Chicago’s budget standoff intensified Wednesday when a coalition of aldermen formally introduced their ...

Recent advancements in pancreatic cancer prognosis have led to the development of the Tianjin Grading System, a tool ...

The dismal debuts of StubHub Holdings Inc., Navan Inc. and Gemini Space Station Inc. have contributed to IPOs as an asset class underperforming the S&P 500 Index this year. That sits uneasily with the ...

Neonatal Toxicology Market to reach USD 931.7 Mn by 2035 at 10.9% CAGR, driven by rising prenatal substance exposure and ...